1. Home
  2. FEBO vs MRKR Comparison

FEBO vs MRKR Comparison

Compare FEBO & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEBO
  • MRKR
  • Stock Information
  • Founded
  • FEBO 1993
  • MRKR N/A
  • Country
  • FEBO Hong Kong
  • MRKR United States
  • Employees
  • FEBO N/A
  • MRKR N/A
  • Industry
  • FEBO
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEBO
  • MRKR Health Care
  • Exchange
  • FEBO Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • FEBO 14.0M
  • MRKR 21.9M
  • IPO Year
  • FEBO 2023
  • MRKR N/A
  • Fundamental
  • Price
  • FEBO $1.27
  • MRKR $1.57
  • Analyst Decision
  • FEBO
  • MRKR Strong Buy
  • Analyst Count
  • FEBO 0
  • MRKR 1
  • Target Price
  • FEBO N/A
  • MRKR $19.00
  • AVG Volume (30 Days)
  • FEBO 8.4K
  • MRKR 95.6K
  • Earning Date
  • FEBO 10-03-2024
  • MRKR 03-25-2025
  • Dividend Yield
  • FEBO N/A
  • MRKR N/A
  • EPS Growth
  • FEBO N/A
  • MRKR N/A
  • EPS
  • FEBO N/A
  • MRKR N/A
  • Revenue
  • FEBO $16,319,897.00
  • MRKR $5,395,849.00
  • Revenue This Year
  • FEBO N/A
  • MRKR $64.48
  • Revenue Next Year
  • FEBO N/A
  • MRKR N/A
  • P/E Ratio
  • FEBO N/A
  • MRKR N/A
  • Revenue Growth
  • FEBO 9.01
  • MRKR 79.04
  • 52 Week Low
  • FEBO $1.20
  • MRKR $1.48
  • 52 Week High
  • FEBO $17.68
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • FEBO 38.48
  • MRKR 35.08
  • Support Level
  • FEBO $1.20
  • MRKR $1.53
  • Resistance Level
  • FEBO $1.39
  • MRKR $1.79
  • Average True Range (ATR)
  • FEBO 0.09
  • MRKR 0.18
  • MACD
  • FEBO 0.01
  • MRKR 0.03
  • Stochastic Oscillator
  • FEBO 24.22
  • MRKR 14.52

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Share on Social Networks: